Real-time SEC alerts Start Free →
Profitelligence
TEVA
TEVA LOW Impact

TEVA

Teva Pharmaceutical Reports Third Quarter 2024 Financial Results

| 8-K

Summary

On November 6, 2024, Teva Pharmaceutical Industries Ltd. announced its financial results for the third quarter of 2024. The company furnished a press release with financial details, which is incorporated by reference from this 8-K report. While the specific financial data and analysis were not provided in the 8-K, the announcement signifies the company's adherence to its regulatory obligations by disclosing key financial outcomes for the period.

Profitelligence Profitelligence Alerts

Get alerts for TEVA

Be first to know when TEVA files with the SEC.

Set Up Alerts →

Filing Categories

General Statement No viable tag

Exhibits (1)

Advertisement

Official SEC Documents

TEVA
TEVA Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement